Amido-Bridged Nucleic Acid-Modified Antisense Oligonucleotides Targeting SYT13 to Treat Peritoneal Metastasis of Gastric Cancer
Open Access
- 5 October 2020
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy Nucleic Acids
- Vol. 22, 791-802
- https://doi.org/10.1016/j.omtn.2020.10.001
Abstract
No abstract availableFunding Information
- Japan Agency for Medical Research and Development
This publication has 43 references indexed in Scilit:
- The multiple roles of amphiregulin in human cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2011
- The EGFR Ligands Amphiregulin and Heparin-Binding EGF-like Growth Factor Promote Peritoneal Carcinomatosis in CXCR4-Expressing Gastric CancerClinical Cancer Research, 2011
- CXCL12 (SDF1α)-CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anticancer Therapies?Clinical Cancer Research, 2011
- Exogenous expression of synaptotagmin XIII suppresses the neoplastic phenotype of a rat liver tumor cell line through molecular pathways related to mesenchymal to epithelial transitionExperimental and Molecular Pathology, 2010
- Suppression of cellular proliferation and invasion by the concerted lipid and protein phosphatase activities of PTENOncogene, 2009
- Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasisAnnals of Oncology, 2009
- Phase I Pharmacokinetic Study of Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Advanced Gastric CancerOncology, 2009
- Phase II Study of a Combination of S-1 and Paclitaxel in Patients with Unresectable or Metastatic Gastric CancerOncology, 2008
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trialThe Lancet Oncology, 2008
- Synaptotagmin 13: Structure and expression of a novel synaptotagminEuropean Journal of Cell Biology, 2001